Quant Biomarkers AG is a data-driven biotechnology company that develops quantitative biomarkers for assessing human longevity and personalized biomarker panels for early detection of age-related chronic diseases. The company builds AI-based risk-prediction algorithms, tissue-specific diagnostic panels, personalized intervention protocols, and digital-twin applications.
AI-generated
Comparisons
Quant Biomarkers AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Quant Biomarkers AG by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.